These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 22717246)

  • 21. Dehydroepiandrosterone administration before IVF in poor responders: a prospective cohort study.
    Vlahos N; Papalouka M; Triantafyllidou O; Vlachos A; Vakas P; Grimbizis G; Creatsas G; Zikopoulos K
    Reprod Biomed Online; 2015 Feb; 30(2):191-6. PubMed ID: 25498594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DHEA administration in poor responders.
    Kolibianakis EM; Venetis CA; Tarlatzis BC
    Hum Reprod; 2011 Mar; 26(3):730-1; author reply 731. PubMed ID: 21242147
    [No Abstract]   [Full Text] [Related]  

  • 23. Dehydroepiandrosterone improves the ovarian reserve of women with diminished ovarian reserve and is a potential regulator of the immune response in the ovaries.
    Zhang J; Qiu X; Gui Y; Xu Y; Li D; Wang L
    Biosci Trends; 2015 Dec; 9(6):350-9. PubMed ID: 26781792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of Dehydroepiandrosterone (DHEA) to overcome the effect of ovarian ageing (DITTO): A proof of principle double blinded randomized placebo controlled trial.
    Narkwichean A; Maalouf W; Baumgarten M; Polanski L; Raine-Fenning N; Campbell B; Jayaprakasan K
    Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():39-48. PubMed ID: 28934714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dehydroepiandrosterone supplementation improves predictive markers for diminished ovarian reserve: serum AMH, inhibin B and antral follicle count.
    Yilmaz N; Uygur D; Inal H; Gorkem U; Cicek N; Mollamahmutoglu L
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):257-60. PubMed ID: 23664458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What is the role of dehydroepiandrosterone in gynecologic practice?
    Gajarawala SN; Wood TA; Stanton AP
    JAAPA; 2019 Dec; 32(12):11-12. PubMed ID: 31770299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of dehydroepiandrosterone supplementation on ovarian response is associated with androgen receptor in diminished ovarian reserve women.
    Hu Q; Hong L; Nie M; Wang Q; Fang Y; Dai Y; Zhai Y; Wang S; Yin C; Yang X
    J Ovarian Res; 2017 May; 10(1):32. PubMed ID: 28472976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A systematic review and meta-analysis of randomized placebo-controlled trials of DHEA treatment effects on quality of life in women with adrenal insufficiency.
    Alkatib AA; Cosma M; Elamin MB; Erickson D; Swiglo BA; Erwin PJ; Montori VM
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3676-81. PubMed ID: 19773400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of dehydroepiandrosterone on in vivo ovine follicular development.
    Narkwichean A; Jayaprakasan K; Maalouf WE; Hernandez-Medrano JH; Pincott-Allen C; Campbell BK
    Hum Reprod; 2014 Jan; 29(1):146-54. PubMed ID: 24256992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene expression of cumulus cells in women with poor ovarian response after dehydroepiandrosterone supplementation.
    Tsui KH; Lin LT; Horng HC; Chang R; Huang BS; Cheng JT; Wang PH
    Taiwan J Obstet Gynecol; 2014 Dec; 53(4):559-65. PubMed ID: 25510701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does dehydroepiandrosterone have any benefit in fertility treatment?
    Urman B; Yakin K
    Curr Opin Obstet Gynecol; 2012 Jun; 24(3):132-5. PubMed ID: 22327737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DHEA supplementation may improve IVF outcome in poor responders: a proposed mechanism.
    Hyman JH; Margalioth EJ; Rabinowitz R; Tsafrir A; Gal M; Alerhand S; Algur N; Eldar-Geva T
    Eur J Obstet Gynecol Reprod Biol; 2013 May; 168(1):49-53. PubMed ID: 23312476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DHEA--finding a role for this enigmatic hormone.
    Fenton A; Panay N
    Climacteric; 2013 Jun; 16(3):303-4. PubMed ID: 23672655
    [No Abstract]   [Full Text] [Related]  

  • 34. The Application of Dehydroepiandrosterone on Improving Mitochondrial Function and Reducing Apoptosis of Cumulus Cells in Poor Ovarian Responders.
    Lin LT; Wang PH; Wen ZH; Li CJ; Chen SN; Tsai EM; Cheng JT; Tsui KH
    Int J Med Sci; 2017; 14(6):585-594. PubMed ID: 28638275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Doping Status of DHEA Treatment for Female Athletes with Adrenal Insufficiency.
    Handelsman DJ; Matsumoto AM; Gerrard DF
    Clin J Sport Med; 2017 Jan; 27(1):78-85. PubMed ID: 26844622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Premature ovarian insufficiency: how to improve reproductive outcome?
    Ben-Nagi J; Panay N
    Climacteric; 2014 Jun; 17(3):242-6. PubMed ID: 24341612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of dehydroepiandrosterone on the ovarian reserve and pregnancy outcomes in perimenopausal rats (DHEA and fertility in perimenopausal rats).
    Mahmoud YI; Mahmoud AA; Abo-Zeid FS; Fares NH
    Life Sci; 2018 Apr; 199():131-138. PubMed ID: 29526798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [DHEA: orthodox or alternative medicine?].
    Cogan E
    Rev Med Brux; 2001 Sep; 22(4):A381-6. PubMed ID: 11680205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DHEA: the last elixir.
    Prescrire Int; 2002 Aug; 11(60):118-23. PubMed ID: 12199273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoandrogenism in association with diminished functional ovarian reserve.
    Gleicher N; Kim A; Weghofer A; Kushnir VA; Shohat-Tal A; Lazzaroni E; Lee HJ; Barad DH
    Hum Reprod; 2013 Apr; 28(4):1084-91. PubMed ID: 23427231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.